Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00385840Phase 2Completed
Phase 2, randomised, double-blind trial of GSK1247446A in influenza, sponsored by GSK. Primary endpoint: Number of Subjects With Any and Grade 3 Solicited Local Symptoms at 7 days. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00385840.